"In recent years … there has been a significant increase in the availability of large-scale open data for drug discovery. In particular, the number and size of screening databases has expanded significantly."

[1]  Peter Wipf,et al.  Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments. , 2010, Assay and drug development technologies.

[2]  David M. Reif,et al.  In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project , 2009, Environmental health perspectives.

[3]  Evan Bolton,et al.  An overview of the PubChem BioAssay resource , 2009, Nucleic Acids Res..

[4]  Egon L. Willighagen,et al.  CDK-Taverna: an open workflow environment for cheminformatics , 2010, BMC Bioinformatics.

[5]  Lee Harland,et al.  Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery , 2009, Nature Reviews Drug Discovery.

[6]  T. Willson,et al.  Open access chemical and clinical probes to support drug discovery. , 2009, Nature chemical biology.

[7]  Lorenz C. Blum,et al.  970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. , 2009, Journal of the American Chemical Society.

[8]  Martin Jones,et al.  IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels , 2008, Nucleic Acids Res..

[9]  C. Bizer,et al.  Enabling Tailored Therapeutics with Linked Data , 2009 .

[10]  D. Young,et al.  Are the Chemical Structures in Your QSAR Correct , 2008 .

[11]  John P. Overington,et al.  Genomic-scale prioritization of drug targets: the TDR Targets database , 2008, Nature Reviews Drug Discovery.

[12]  Nicole Tourigny,et al.  Bio2RDF: Towards a mashup to build bioinformatics knowledge systems , 2008, J. Biomed. Informatics.

[13]  A. Hunter,et al.  The Innovative Medicines Initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients. , 2008, Drug discovery today.

[14]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[15]  Martin Serrano,et al.  Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .

[16]  James Inglese,et al.  Reporting data from high-throughput screening of small-molecule libraries. , 2007, Nature chemical biology.

[17]  Olivier Sperandio,et al.  Free resources to assist structure-based virtual ligand screening experiments. , 2007, Current protein & peptide science.

[18]  S. Arnesen,et al.  Environmental Health and Toxicology Resources of the United States National Library of Medicine , 2007, Medical reference services quarterly.

[19]  Christopher P Austin,et al.  A high-throughput screen for aggregation-based inhibition in a large compound library. , 2007, Journal of medicinal chemistry.

[20]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[21]  Thorsten Meinl,et al.  KNIME: The Konstanz Information Miner , 2007, GfKl.

[22]  Egon L. Willighagen,et al.  Bioclipse: an open source workbench for chemo- and bioinformatics , 2007, BMC Bioinformatics.

[23]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[24]  Ann M Richard,et al.  Distributed structure-searchable toxicity (DSSTox) public database network: a proposal. , 2002, Mutation research.